Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Gettysburg Baseball’s Take ALS Yard 2022
Last month, Coach John Campo and Gettysburg Bullets Baseball held their annual “Take ALS Yard” event at Kirchhoff Field
May 10, 2022
No Comments
